Corcept Therapeutics

Connections 1

Description

Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol.

The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. It has marketed Korlym (mifepristone) for the treatment of patients suffering from Cushing’s syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant.

Its cortisol activity can be modulated by a drug that competes with cortisol as it attempts to bind to the glucocorticoid receptor (GR). The Company’s ingredient, mifepristone, reduces the binding of excess cortisol to GR. Its compounds bind to GR but not the progesterone, estrogen, or androgen receptors.

Website

http://www.corcept.com

Rating GlobalNY.biz

Take place №2790 In rating New York Organizations general
Take place №258 In rating Healthcare area

<!-- advertisement 10-->
<div class="mobileShow">
<script>
  atOptions = {
    'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
    'format' : 'iframe',
    'height' : 250,
    'width' : 300,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script>
  atOptions = {
    'key' : '60966449084d21264769e3d9bdff986a',
    'format' : 'iframe',
    'height' : 90,
    'width' : 728,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

31 March 2022

Business

New York Stock Exchange opens with decline in key indices on Thursday

Falling at the start of trading The New York Stock Exchange opened Thursday with key indices down 0...

<!-- advertisement 12-->
<div class="mobileShow">
<script type="text/javascript">
	atOptions = {
		'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
		'format' : 'iframe',
		'height' : 250,
		'width' : 300,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script type="text/javascript">
	atOptions = {
		'key' : '60966449084d21264769e3d9bdff986a',
		'format' : 'iframe',
		'height' : 90,
		'width' : 728,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

OPPENHEIM Lance

I’m excited for him to ‘have a seat’ and watch the movie in a movie theater, if that’s where he chooses to watch it.

PAUL Frankie Taylor

[I said,] ‘Yes.’ Yes, I did [get engaged]

BULLOCK Sandra

We thought, ‘This is going to be such an amazing film. People are going to love it.’ And then it got quiet. It got quiet

KAZANKOV Dmitry Alexandrovich

It works excellently in tandem with documentary genealogy: confirming or refuting hypotheses, finding unknown relatives, and breaking through brick walls. But expecting the test to build a pedigree back to the 16th century on its own is an illusion. Without archives, parish registers, and competent analysis of matches, the test remains just a set of percentages. We always advise users to first establish a documentary foundation and only then verify it with DNA data